Study on Predictive Factors of Anti-Angiogenesis Therapy Combined with Neoadjuvant Chemotherapy for Phase IIIA Non-Small Cell Lung Cancer

被引:0
作者
Wang, Changli [1 ]
机构
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Thorac Oncol, Tianjin, Peoples R China
关键词
anti-angiogenesis; neoadjuvant chemotherapy; non-small cell lung cancer; Endostar; predictive factors;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PUB036
引用
收藏
页码:S771 / S771
页数:1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in non small cell lung cancer
    Besse, Benjamin
    Vignot, Stephane
    Le Chevalier, Thierrv
    [J]. BULLETIN DU CANCER, 2006, 93 (11) : 1087 - 1092
  • [22] Randomized controlled trial of neoadjuvant chemotherapy with cisplatin and vinorelbine in patients with stage IIIA non-small cell lung cancer in China
    Li, Jian
    Yu, Li-Chao
    Chen, Ping
    Shi, Sheng-Bing
    Dai, Chun-Hua
    Wu, Jian-Rong
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 87 - 94
  • [23] Neoadjuvant and adjuvant therapy of non-small cell lung cancer
    Rajdev, L
    Keller, SM
    [J]. SURGICAL ONCOLOGY-OXFORD, 2002, 11 (04): : 243 - 253
  • [24] Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer
    Chuang, Jody C.
    Liang, Ying
    Wakelee, Heather A.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 31 - +
  • [25] Neoadjuvant therapy for non-small cell lung cancer and esophageal cancer
    He, Yunlong
    Zhao, Yaqi
    Akhtar, Muhammad Luqman
    Li, Yu
    Mingyan, E.
    Nie, Huan
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (03): : 1258 - 1277
  • [26] Neoadjuvant chemotherapy for early stage non-small cell lung cancer
    Beitler, AL
    Urschel, JD
    Takita, H
    [J]. MEDICAL SCIENCE RESEARCH, 1998, 26 (12): : 853 - 854
  • [27] Clinical Study of Anti-Angiogenesis Therapy Combined with Neo-Adjuvant Chemotherapy on NSCLC Patients in Phase IIIa (N2)
    Zhao, Xiao-Liang
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S547 - S547
  • [28] Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)
    Elias, AD
    Skarin, AT
    Leong, T
    Mentzer, S
    Strauss, G
    Lynch, T
    Shulman, L
    Jacobs, C
    Abner, A
    Baldini, EH
    Frei, E
    Sugarbaker, DJ
    [J]. LUNG CANCER, 1997, 17 (01) : 147 - 161
  • [29] Neoadjuvant Combination Sintilimab plus Chemotherapy in Patients with Resectable Stage IIIA Non-Small Cell Lung Cancer.
    Ma, K.
    Sun, C.
    Jia, X.
    Wang, X.
    Xu, Y.
    Guo, Y.
    Qiu, S.
    Shao, G.
    Zhang, P.
    Liu, Y.
    Ma, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S649 - S650
  • [30] EFFECT OF NEOADJUVANT CHEMOTHERAPY USING PACLITAXEL COMBINED WITH CARBOPLATIN ON ADVANCED NON-SMALL CELL LUNG CANCER
    熊宏超
    陈晋峰
    张力建
    [J]. ChineseJournalofCancerResearch, 2006, (03) : 218 - 221